This company listing is no longer active
TCR2 Therapeutics Dirección
Dirección controles de criterios 3/4
TCR2 Therapeutics' CEO is Garry Menzel, appointed in Jan 2016, they has a tenure of 7.42 years. Their total yearly compensation is $1.74M , comprised of 34.5% salary and 65.5% bonuses, including company stock and options. They directly owns 1.03% of the company’s shares, worth €558.91K. The average tenure of the management team and the board of directors is 2.5 years and 3.8 years respectively.
Información clave
Garry Menzel
Chief Executive Officer (CEO)
US$1.7m
Compensación total
| Porcentaje del salario del CEO | 34.5% |
| Permanencia del CEO | 7.4yrs |
| Participación del CEO | 1.0% |
| Permanencia media de la dirección | 2.5yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$163m |
| Dec 31 2022 | US$2m | US$603k | -US$152m |
| Sep 30 2022 | n/a | n/a | -US$119m |
| Jun 30 2022 | n/a | n/a | -US$115m |
| Mar 31 2022 | n/a | n/a | -US$107m |
| Dec 31 2021 | US$2m | US$580k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$91m |
| Jun 30 2021 | n/a | n/a | -US$81m |
| Mar 31 2021 | n/a | n/a | -US$73m |
| Dec 31 2020 | US$6m | US$560k | -US$67m |
| Sep 30 2020 | n/a | n/a | -US$61m |
| Jun 30 2020 | n/a | n/a | -US$58m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$8m | US$492k | -US$97m |
| Sep 30 2019 | n/a | n/a | -US$96m |
| Jun 30 2019 | n/a | n/a | -US$100m |
| Mar 31 2019 | n/a | n/a | -US$107m |
| Dec 31 2018 | US$3m | US$436k | -US$62m |
| Sep 30 2018 | n/a | n/a | -US$55m |
| Dec 31 2017 | US$792k | US$423k | -US$15m |
Compensación vs. Mercado: Garry's total compensation ($USD1.74M) is above average for companies of similar size in the German market ($USD410.59K).
Compensación vs. Ingresos: Garry's compensation has been consistent with company performance over the past year.
CEO
Garry Menzel (59 yo)
7.4yrs
Permanencia
US$1,744,815
Compensación
Dr. Garry E. Menzel, Ph D., M.B.A. serves as an Independent Director at Black Diamond Therapeutics, Inc. since March 2017. He is a co-founder of Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.4yrs | US$1.74m | 1.03% $ 558.9k | |
| Chief Medical Officer | 6.4yrs | US$1.01m | 0.28% $ 151.3k | |
| Chief Business & Strategy Officer | 1.4yrs | US$1.07m | 0% $ 0 | |
| Founder & Member of the Advisory Board | no data | US$47.02k | sin datos | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Chief Operating Officer | less than a year | US$2.74m | 0.061% $ 33.3k | |
| Senior Director of Investor Relations & Corporate Communications | no data | sin datos | sin datos | |
| General Counsel | 5.4yrs | sin datos | sin datos | |
| Chief People Officer | 3.7yrs | sin datos | 0.12% $ 67.4k | |
| Vice President of Corporate Controller | 1.1yrs | sin datos | sin datos |
2.5yrs
Permanencia media
49yo
Promedio de edad
Equipo directivo experimentado: 2K7's management team is considered experienced (2.5 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.4yrs | US$1.74m | 1.03% $ 558.9k | |
| Founder & Member of the Advisory Board | 1.7yrs | US$47.02k | sin datos | |
| Independent Director | 8.1yrs | sin datos | sin datos | |
| Independent Director | 5.3yrs | US$68.42k | 0% $ 0 | |
| Chairman of Advisory Board | no data | US$18.75k | 0% $ 0 | |
| Independent Chairman of the Board | 3.1yrs | US$95.92k | 0% $ 0 | |
| Independent Director | 4.5yrs | US$63.42k | 0% $ 0 | |
| Independent Director | 3.2yrs | US$54.92k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$59.92k | 0% $ 0 | |
| Member of Advisory Board | no data | sin datos | sin datos | |
| Member of the Advisory Board | no data | sin datos | sin datos | |
| Member of Advisory Board | no data | sin datos | sin datos |
3.8yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: 2K7's board of directors are considered experienced (3.8 years average tenure).